Silverman Joshua is Interim CEO, Interim President of PharmaCyte Biotech Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Apr 24 | SNPX Synaptogenix | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 5.39 | 800 | 4.31 k | 800 |
21 Dec 23 | PTPI Petros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 40,000 | 56.40 k | 40,000 |
21 Nov 23 | FEMY Femasys | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9 | 17,000 | 15.30 k | 17,000 |
20 Nov 23 | PMCB PharmaCyte Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 2.18 | 170,000 | 370.60 k | 170,000 |